Cancers (Feb 2023)

PD-1<sup>+</sup>CD8<sup>+</sup> T Cells Proximal to PD-L1<sup>+</sup>CD68<sup>+</sup> Macrophages Are Associated with Poor Prognosis in Pancreatic Ductal Adenocarcinoma Patients

  • Xiaobao Yang,
  • Guanzheng Wang,
  • Yue Song,
  • Tongtao Zhuang,
  • Yifei Li,
  • Yujie Xie,
  • Xuefeng Fei,
  • Yanan Zhao,
  • Dakang Xu,
  • Yiqun Hu

DOI
https://doi.org/10.3390/cancers15051389
Journal volume & issue
Vol. 15, no. 5
p. 1389

Abstract

Read online

Immune complexity status in the TME has been linked to clinical outcomes in pancreatic ductal adenocarcinoma (PDAC) patients. TME assessments with current cell marker and cell density-based analyses do not identify the original phenotypes of single cells with multilineage selectivity, the functional status of the cells, or cellular spatial information in the tissues. Here, we describe a method that circumvents these problems. The combined strategy of multiplexed IHC with computational image cytometry and multiparameter cytometric quantification allows us to assess multiple lineage-selective and functional phenotypic biomarkers in the TME. Our study revealed that the percentage of CD8+ T lymphoid cells expressing the T cell exhaustion marker PD-1 and the high expression of the checkpoint PD-L1 in CD68+ cells are associated with a poor prognosis. The prognostic value of this combined approach is more significant than that of lymphoid and myeloid cell density analyses. In addition, a spatial analysis revealed a correlation between the abundance of PD-L1+CD68+ tumor-associated macrophages and PD-1+CD8+T cell infiltration, indicating pro-tumor immunity associated with a poor prognosis. These data highlight the implications of practical monitoring for understanding the complexity of immune cells in situ. Digital imaging and multiparameter cytometric processing of cell phenotypes in the TME and tissue architecture can reveal biomarkers and assessment parameters for patient stratification.

Keywords